

Codexis is a biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics. Among its major competitors, Codexis is ranked in 8th place for NPS while Gevo is 1st, and ADM is 2nd.Their current market cap is $172.93M